Skip to main content

Market Overview

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Consumer Staples Industry: Personal Products

0.4050 0.005 (1.25%)

Data as of May 07, 2021

Prev. Close 0.4
Price Open 0.41895
Volume 62,403
Day's Range 0.4 - 0.41895
52 Wk Range 0.36 - 1.27
50 Day Moving Avg. 0.41
PE Ratio
Shares Outstanding 106.79M
Market Cap 43.25M

Trade CVSI stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

Cannabis Stock Gainers And Losers From April 7, 2021 Jose Rodrigo SafdiyeWed, 07 Apr 2021 17:13:18 -0400
Cannabis Stock Gainers And Losers From April 5, 2021 Jose Rodrigo SafdiyeMon, 05 Apr 2021 17:13:27 -0400
Cannabis Stock Gainers And Losers From March 24, 2021 Jose Rodrigo SafdiyeWed, 24 Mar 2021 17:14:01 -0400
Cannabis Stock Gainers And Losers From March 19, 2021 Jose Rodrigo SafdiyeFri, 19 Mar 2021 17:25:20 -0400
Benzinga's Top Ratings Upgrades, Downgrades For March 19, 2021 Benzinga InsightsFri, 19 Mar 2021 10:03:10 -0400
Roth Capital Maintains Neutral on CV Sciences, Lowers Price Target to $0.6 Benzinga NewsdeskFri, 19 Mar 2021 08:59:23 -0400
Piper Sandler Downgrades CV Sciences to Neutral, Announces $0.5 Price Target vishwanath@benzinga.comFri, 19 Mar 2021 06:55:02 -0400
CV Sciences Q4 Sales $5.20M Miss $6.63M Estimate Benzinga NewsdeskThu, 18 Mar 2021 16:12:59 -0400
A Preview Of CV Sciences's Earnings Benzinga InsightsWed, 17 Mar 2021 10:39:49 -0400
Cannabis Stock Gainers And Losers From March 16, 2021 Jose Rodrigo SafdiyeTue, 16 Mar 2021 17:19:50 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021 Globe Newswire1 day ago
CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology's Cannabis Quality Assurance Program Globe NewswireApr 13, 2021
CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results Globe NewswireMar 18, 2021
CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021 Globe NewswireMar 10, 2021
Global CBD Based Skin Care Market Could Exceed $3.45 Billion By 2026 PRNewswireFeb 18, 2021
Global CBD Consumers Continue to Gain More Offerings as Market Regulations Around the World Solidify PRNewswireFeb 17, 2021
CV Sciences, Inc. Announces Launch of ProCBD™ Product Line Globe NewswireJan 05, 2021
CV Sciences, Inc. Receives Nutritional Outlook's 2020 Best of the Industry Award Globe NewswireDec 10, 2020
CV Sciences, Inc. Announces Closing of Committed Equity Financing Transaction Globe NewswireDec 08, 2020
CV Sciences, Inc. Reports Third Quarter 2020 Financial Results Globe NewswireNov 05, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

CV Sciences and Alkemist Labs team up in Cannabis quality assurance program Seeking AlphaApr 13, 2021
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q4 2020 Results - Earnings Call Transcript Seeking AlphaMar 18, 2021
CV Sciences EPS beats by $0.01, misses on revenue Seeking AlphaMar 18, 2021
CV Sciences cut at Cantor Fitzgerald with profitability seen as still far off Seeking AlphaJan 29, 2021
4 Marijuana Penny Stocks Winning Under Democratic Leadership InvestorPlaceJan 14, 2021
Neptune Wellness: Changes Focus And Revenues Soar Upward Seeking AlphaDec 14, 2020
CV Sciences: CBD Is All The Rage Yet This Stock Will Get Ravaged Seeking AlphaDec 03, 2020
CV Sciences Inc's (CVSI) CEO Joe Dowling on Q3 2020 Results - Earnings Call Transcript Seeking AlphaNov 06, 2020
CV Sciences' (CVSI) CEO Joseph Dowling on Q2 2020 Results - Earnings Call Transcript Seeking AlphaAug 06, 2020
CV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product Line GuruFocusAug 05, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Earnings View Earnings

Q4 2020	EST	Actual	Surprise
EPS:	-0.020	-0.020	0.0000
Rev:	6.63M	5.20M	-1.43M

Q1 2021	EST	Actual	Surprise
EPS:	Expected 2021-05-18
Rev:	Expected 2021-05-18

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses